Abstract
Introduction Usability is an overlooked aspect of implementing lab-based assays, particularly novel assays in low-resource-settings. Esoteric instructions can lead to irreproducible test results and patient harm. To address these issues, we developed a software application based on “Aquarium”, a laboratory-operating system run on a computer tablet that provides step-by-step digital interactive instructions, protocol management, and sample tracking. Aquarium was paired with a near point-of-care HIV drug resistance test, “OLA-Simple”, that detects mutations associated with virologic failure. In this observational study we evaluated the performance of Aquarium in guiding untrained users through the multi-step laboratory protocol with little supervision.
Methods A feasibility study was conducted in a laboratory at Coptic Hope Center in Nairobi, Kenya. To evaluate the training by Aquarium software, twelve volunteers who were unfamiliar with the kit performed the test on blinded samples (2 blood specimens; 5 codons/sample). Steps guided by Aquarium included: CD4+ T-Cell separation, PCR, ligation, detection, and interpretation of test results. Participants filled out a short survey regarding their demographics and experience with the software and kit.
Results and discussion 12/12 laboratory technicians had no prior experience performing CD4+ separation and 7/12 had no experience performing laboratory-based molecular assays. 12/12 isolated CD4+ T cells from whole blood with yields comparable to isolations performed by trained personnel. The OLA-Simple workflow was completed by all, with correct visual and software interpretation of results for 90% (108/120) and 97% (116/120) of codons, respectively. In the surveys, participants favorably assessed the use of software guidance.
Conclusions Aquarium digital instructions enabled first-time users in Kenya to complete the OLA-simple kit workflow with minimal training. Aquarium could increase the accessibility of laboratory assays in low-resource-settings and potentially standardize implementation of clinical laboratory tests.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by R01 AI110375 (LMF); R01 AI145486-01A1 (BRL); T32 HD007233 (RK); and UW Bioengineering Pilcher Faculty Fellowship (BRL). The content of this work is not influenced by funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Ethics Review Committee (IERC) of the Aga Khan University in Kenya and Seattle Childrens Research Institutes IRB.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of authors: JDV: jvrana{at}uw.edu
NP: nuttadap{at}uw.edu
NH: nhiga{at}usc.edu
DK: Daisy.Ko{at}seattlechildrens.org
PR: psr23{at}uw.edu
RK: Ruth.M.Kanthula{at}gunet.georgetown.edu
JJL: jilai{at}uw.edu
YY: yaoyu{at}uw.edu
SRS: amsa737{at}gmail.com
BC: bchohan{at}uw.edu
MHC: mhchung{at}uw.edu
LMF: lfrenkel{at}uw.edu
BRL: blutz{at}uw.edu
Data Availability
All data were available in the main text and supplementary information.